fluorescent dyes DNA Script Exclusively Licenses Modified DNA Printing Technology From Baseclick The Paris-based company plans to use the nucleic acid modification technology to synthesize qPCR probes for use in diagnostics, among other biomolecules. Expansion Sequencing Improves on Church Lab's In Situ Transcriptomics Method Premium Researchers have developed a higher-resolution in situ RNA sequencing method that relies on physically expanding a polymer network that holds the RNA. 10x Genomics to Acquire ReadCoor for $350M, Cartana for $41.2M The deals give 10x Genomics control of a combined 110 patents covering in situ analysis methods that the firm says will complement its existing platforms. Phitonex Closes $2M Seed Financing Round The startup has developed a platform that allows precise engineering of optical properties to provide high-resolution analysis of single cells by high throughput flow cytometry. Quantapore Working Towards Commercialization of Optical Nanopore Sequencing Tech Premium The Menlo Park, California-based company plans to demonstrate its sequencing technology on a small genome in the near future. Aug 16, 2017 Single-Color Digital PCR Method Shows Promise for Blood-Based Cancer Monitoring Premium Dec 20, 2012 Bio-Rad Commercializing Lamprogen's Fluorescent Particles Oct 12, 2012 TriLink, Li-Cor Ink Oligo Dye Deal Aug 27, 2012 BD Buys Sirigen Feb 9, 2011 AnaSpec, In Vitro Ink Distribution Deal Mar 17, 2010 Enzo, Cancer Genetics Enter into Dye Labels Pact Breaking News Canadian Healthcare Providers, Policymakers Value Different Aspects of Clinical Genomic Sequencing New Products Posted to GenomeWeb: Oxford Nanopore, Bio-Rad, NanoString, More People in the News at OraSure, Element Biosciences, Micronoma, More Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study The Scan Blend of Omicron With Delta The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant. Limited Contrast The New York Times reports that there is a shortage of a contrast agent used for some medical scans. Pig Improvement Farmers in China are using genetics to improve their hog herds, according to Reuters. Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.